Theophylline Fpia Reagent Set
by Sigma Diagnostics, Inc. 510(k)
Active
510(k) K870952
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK870952 | Date31 Mar 1987 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- KLS
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3880
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Theophylline Fpia Reagent Set is an enzyme immunoassay device used for the quantitative determination of theophylline in human serum or plasma. This reagent set is designed to assist in the clinical monitoring of theophylline levels.
This device is supplied by Sigma Diagnostics, Inc. and has received FDA 510(k) clearance under K870952. It is classified under regulation number 862.3880 within the clinical toxicology medical specialty.
Other devices from Sigma Diagnostics, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the primary clinical use of the Theophylline FPIA Reagent Set?
This device is used for the quantitative determination of theophylline levels in human serum or plasma samples. It is specifically designed to assist clinicians in the ongoing monitoring of theophylline concentrations in patients.
What regulatory classification does this device hold?
The Theophylline FPIA Reagent Set is classified under regulation number 862.3880 within the clinical toxicology medical specialty. It has received FDA 510(k) clearance under submission number K870952.
Who is the manufacturer of this reagent set?
This device is manufactured by Sigma Diagnostics, Inc., located in St. Louis, Missouri. The company is the applicant of record for the FDA 510(k) clearance associated with this product.